Centogene N.V. (CNTG)
NASDAQ: CNTG · IEX Real-Time Price · USD
0.520
-0.001 (-0.10%)
Jul 19, 2024, 4:00 PM EDT - Market open
Centogene Employees
Centogene had 384 employees as of December 31, 2023. The number of employees decreased by 60 or -13.51% compared to the previous year.
Employees
384
Change (1Y)
-60
Growth (1Y)
-13.51%
Revenue / Employee
$140,440
Profits / Employee
-$103,597
Market Cap
15.07M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
China Jo-Jo Drugstores | 938 |
BIMI International Medical | 296 |
Star Equity Holdings | 171 |
Talis Biomedical | 99 |
Evaxion Biotech | 49 |
Edesa Biotech | 16 |
BriaCell Therapeutics | 16 |
Talphera | 15 |
CNTG News
- 4 weeks ago - C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development - GlobeNewsWire
- 7 weeks ago - CENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General Meeting - GlobeNewsWire
- 2 months ago - CENTOGENE Reports Full Year 2023 Financial Results and Recent Business Highlights - GlobeNewsWire
- 2 months ago - CENTOGENE Secures Approx. $20 Million to Strengthen Cash Position - GlobeNewsWire
- 2 months ago - CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease - GlobeNewsWire
- 2 months ago - CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients - GlobeNewsWire
- 3 months ago - CENTOGENE Receives Nasdaq Non-Compliance Notice - GlobeNewsWire
- 4 months ago - CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders - GlobeNewsWire